Dopaminergic Impact on Cortical Excitability in Humans

Clozapine, GABAB, and the Treatment of Resistant Schizophrenia

(2009) Z J Daskalakis et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

D1-Receptor Impact on Neuroplasticity in Humans

(2009) M. A. Nitsche et al.   JOURNAL OF NEUROSCIENCE

The Dual-State Theory of Prefrontal Cortex Dopamine Function with Relevance to Catechol-O-Methyltransferase Genotypes and Schizophrenia

(2008) Daniel Durstewitz et al.   BIOLOGICAL PSYCHIATRY

l-dopa modulates motor cortex excitability in Alzheimer’s disease patients

(2008) Alessandro Martorana et al.   JOURNAL OF NEURAL TRANSMISSION

Increased cortical inhibition in persons with schizophrenia treated with clozapine

(2008) Zafiris J Daskalakis et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Reduced cortical inhibition in first-episode schizophrenia

(2008) T. Wobrock et al.   SCHIZOPHRENIA RESEARCH